| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523316A2 Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 04/20/2005 | EP1523310A2 Method to inhibit ischemia and reperfusion injury |
| 04/20/2005 | EP1383494A4 Compositions and methods for the prevention and treatment of human prostate cancer |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1213290B1 Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 04/20/2005 | EP1129077B1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608068A Bridged bicyclic amino acid-derived [1, 4]benzodiazepine vasopressin receptor antagonists |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607951A Quinoline derivatives as neuropeptide y antagonists |
| 04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 04/20/2005 | CN1606995A Traditional Chinese medicine preparation for treating uremia and its preparation method |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197614C Chinese medicine capsule for treating prostate disease |
| 04/20/2005 | CN1197612C Chinese medicine preparation for treating lithiasis in urinary system and urethral infection, and preparing method thereof |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881405 Reagents and methods for inducing an immune response to prostate specific antigen |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005032588A1 Preparation containing basic drug |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2000051613A3 Upper hitch link |
| 04/14/2005 | US20050080266 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 04/14/2005 | US20050080136 Spray drying in the presence of trehalose, then granulating and drying; leucine, isoleucine, valine powders; oral meltability and solubility and a high masking effect of the taste |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050079167 Surface treated active carbon; controlling particle size, porosity |
| 04/14/2005 | US20050079135 Pharmaceutical formulation comprising lanthanum compounds |
| 04/14/2005 | DE10342423A1 Verwendung von Fumarsäurederivaten zur Prophylaxe und zur Behandlung von Genomschäden The use of fumaric acid derivatives for the prophylaxis and treatment of genomic damage |
| 04/13/2005 | EP1522583A2 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina) |
| 04/13/2005 | EP1522314A1 Remedies for diseases caused by vascular contraction or dilation |
| 04/13/2005 | EP1521847A2 Marker genes for determining renal toxicity |
| 04/13/2005 | EP1521845A1 Method for detecting increased susceptibility to tumours |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521768A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521597A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 04/13/2005 | EP1521596A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1480736A4 Microcapsules having high carotenoid content |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1090105B1 Non-embryonic ependymal neural stem cells and method for their isolation |
| 04/13/2005 | EP0975349B1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1606432A Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/13/2005 | CN1605343A Application of skimming in the preparing process of medicine for preparing and treating kidney function failure |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196488C Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196475C Bioavailable dosage form of isotretinoin |
| 04/12/2005 | US6878745 Selective preventives/remedies for progressive lesions after organ damage |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/07/2005 | WO2005030960A1 Staple type oligonucleotide and drug comprising the same |
| 04/07/2005 | WO2005030737A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | WO2005018528A3 Method for the treatment prophylaxis and differential diagnosis of prostatitis |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | US20050075396 Modulation of type 2 diabetes and drug delivery |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |